← Back to Search

Behavioral Intervention

Dialectical Behavior Therapy for Borderline Personality Disorder

N/A
Waitlist Available
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 13-17 years or 18-20 if still living at home with parent
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights

Study Summary

This trial will test a new treatment for adolescents with borderline personality disorder.

Who is the study for?
This trial is for adolescents aged 13-20 with borderline personality disorder, showing impulsive behavior or self-harm. They must live close to the clinic and have a caregiver join in treatment. Participants can't be in other talk therapies, must understand English, have an IQ above 70, and not require services for conditions like schizophrenia.Check my eligibility
What is being tested?
The study tests Dialectical Behavior Therapy (DBT-A) specifically designed for teenagers at Rutgers University's DBT Clinic. It involves six months of therapy with assessments throughout the process to track progress and effectiveness.See study design
What are the potential side effects?
As DBT-A is a form of psychological therapy rather than medication, it doesn't have traditional side effects but may bring up emotional discomfort as participants work through personal issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 13-17 years old, or 18-20 and living with my parents.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-Injurious Thoughts and Behaviors Inventory (SITBI)
Work and Social Adjustment Scale
Secondary outcome measures
Borderline Symptom List (BSL-23)
Brief Symptom Inventory (BSI)
Difficulties in Emotion Regulation Scale (DERS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: DBT-AExperimental Treatment1 Intervention
The standard treatment to be delivered to all participants is DBT-A, which is a treatment model adapted from DBT. DBT-A is an adaptation for adolescents with emotion dysregulation and BPD features (Miller, Rathus, & Linehan, 2007; Rathus & Miller, 2015). DBT-A involves weekly individual therapy with the adolescent, weekly multifamily skills group in which adolescents and family members participate, as needed phone coaching, and weekly consultation team for the therapists.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DBT-A
2015
N/A
~60

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
430 Previous Clinical Trials
64,558 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
100 Patients Enrolled for Borderline Personality Disorder

Media Library

DBT-A (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03861858 — N/A
Borderline Personality Disorder Research Study Groups: DBT-A
Borderline Personality Disorder Clinical Trial 2023: DBT-A Highlights & Side Effects. Trial Name: NCT03861858 — N/A
DBT-A (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03861858 — N/A
~45 spots leftby Nov 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top